No Picture
News

PrecisePK Expands Its Global Standing as The Most Trusted Bayesian Dosing Software for South Korea’s Health Systems

SAN DIEGO, March 27, 2023 /PRNewswire/ — Today, PrecisePK, an industry-trusted Bayesian Model-Informed Precision Dosing (MIPD) software, reports its technology is being implemented in many of South Korea’s largest health systems. PrecisePK had secured a […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Faster Slo-Mo?

Whether in sports moments, nature documentaries or animal behavior studies, a new technique developed by UC San Diego computer scientists could have far-reaching impact. In an effort to smooth out slow-mo, they have broken new […]

No Picture
News

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

SAN DIEGO, March 24, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

NEURELIS ANNOUNCES FIRST HEALTHY SUBJECTS DOSED IN INVESTIGATIONAL STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT CEREBRAL CAVERNOUS MALFORMATIONS

First in human study will evaluate safety, tolerability, and pharmacokinetic parameters of NRL-1049, a Rho kinase (ROCK) inhibitor SAN DIEGO, Calif., March 24, 2023 /PRNewswire/ — Neurelis, Inc., announced the first two cohorts dosed in […]

No Picture
News

Enrollment Begins in FORESEE Clinical Trial Using Biocept’s CNSide™ to Evaluate Patients with Leptomeningeal Metastases

SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

Transformative Next Generation Sequencing (NGS) Innovation expands access to genomic testing and enables personalized medicine for patients with Tuberculosis (TB) CAPE TOWN, South Africa, March 24, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global […]

No Picture
News

Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

The Company is seeking strategic opportunities to advance the development of this program SAN DIEGO, March 23, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS

If approved, tofersen will be the first treatment targeting a genetic cause of ALS and the next marketed Ionis-discovered antisense medicine FDA decision expected by April 25, 2023 CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — […]

No Picture
News

DrTalks Presents The Reverse Inflammaging Body and Mind Longevity Medicine Summit to Take Place Virtually on April 25th-May 2nd, 2023

CARLSBAD, Calif., March 22, 2023 /PRNewswire/ — DrTalks.com is pleased to announce the upcoming Reverse Inflammaging Body and Mind Longevity Medicine Summit from April 25th to May 2nd, 2023. The summit will be hosted by […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Technosylva Adds Three New Members to Board

LA JOLLA, Calif. & LEON, Spain–(BUSINESS WIRE)–Technosylva Inc., the leading wildfire science and technology company that operationalizes wildfire science, providing proven wildfire risk analysis solutions to enhance daily decision making for fire agencies and electric […]

No Picture
News

Club Kokomo Spirits Partners with Speakeasy Co. to Launch Online Storefront and Direct-to-Consumer Shipping Nationwide

SAN DIEGO, March 22, 2023 /PRNewswire/ — New premium cocktail and spirits company Club Kokomo Spirits and Speakeasy Co. have announced a distribution partnership, making the California-born brand immediately available to consumers across 34 Sates. […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Clinicians Identify Buprenorphine “Spiking” In JAMA Psychiatry Study Supported by Millennium Health Researchers

SAN DIEGO–(BUSINESS WIRE)–A JAMA Psychiatry study, led by Jarratt D. Pytell, MD, MHS, Department of Medicine, University of Colorado School of Medicine, and co-authored by Brendan Saloner, PhD, Johns Hopkins Bloomberg School of Public Health, […]

No Picture
News

Starlight Cardiovascular Awarded $2.16M NIH SBIR Phase II Grant from National Heart, Lung, and Blood Institute

Award supports design and preclinical testing of pediatric stent SAN DIEGO, March 22, 2023 /PRNewswire/ — Starlight Cardiovascular, Inc., a medical device company developing pediatric cardiovascular devices, announced that it has been awarded a Small […]